Dr. Zabner has significant experience in basic CF research, clinical CF research, and the care of patients with CF. His interests include gene therapy for CF lung disease and mechanisms by which CFTR regulates airway fluid composition and innate immunity, and his research elegantly bridges studies in CF patients with those in CF pig animal models.